维普期刊资源整合服务平台（V6.5）

101篇 您的检索式：作者名="GARRETT CR"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib:A randomised controlled trial显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，：	1
2	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal turnout after failure of imatinib : A randomised controlled trial 显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，：	1
3	Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers:Current state-of-the science显示文摘	Sahin IH Hassan MM Garrett CR	2014	Cancer Letters2014，345，2：	1
4	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumor after failure of imatinib: a randomised controlled trial 显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，9544：	1
5	k- ras mutation may be early e-vent in mucinous ovarian tumorigenesis 显示文摘	Garrett Ap Lee KR Colitti CR	2001	Int J Gynecol pathol2001，20，3：	1
6	Efficacy and safety of suninnib in patients with advanced gastrointestinal stromal tumour after failure of imatinib:a randomized controlled trial显示文摘	Demetri GD van Oosterom AT Garrett CR		0，，9863：	1
7	Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric ade- nocarcinoma patients: Expression differences with potential for specific targeted therapies 显示文摘	Cangiano J Centeno BA Garrett CR	2008	Dig Dis Sci2008，53，8：	1
8	Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia显示文摘	Saglam O Garrett CR Boulware D		0，，09：	1
9	Dual blockade ofHER2 in HER2-overexpressing tumor cells does not com-pletely eliminate HER3 function 显示文摘	Garrett JT Sutton CR Kuba MG	2013	Clin Cancer Res2013，19，3：	1
10	Phase 1 trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies 显示文摘	HOMSI J SIMON GR GARRETT CR	2007	Clin Cancer Res2007，13，19：	1
11	Efficacy andsafety of sunitinib in patients with advanced gastrointestinal stro-mal tumour after failure of imatinib: a randomised controlled tri-al 显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，9544：	1
12	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，9544：	1
13	Covent hypothyroidism presenting as a cardiovascular event显示文摘	LeMar HJ Jr West SG Garrett CR	1991	Am J Med1991，91，：	1
14	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial显示文摘	DEMETRI GD VAN OOSTEROM AT GARRETT CR	2006	Lancet2006，368，9554：	1
15	Covert hypothyroidism presenting as a cardiovascular event 显示文摘	Le Mar HJ Jr West SG Garrett CR	1991	Am J Med1991，91，5：	1
16	Efficacy and safety'of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，9544：	1
17	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，9544：	1
18	Activation of the serine/threonine protein kinase AKT during the progression of eolorectal neoplasia 显示文摘	Saglam O Garrett CR Boulware D	2007	Clin Colorectal Cancer2007，6，9：	1
19	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib , a randomised controlled trial显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，9544：	1
20	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib : a randomised controlled trial 显示文摘	Demetri GD van OAT Garrett CR	2006	Lancet2006，368，9544：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示